Status:
TERMINATED
Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary
Lead Sponsor:
University of Pecs
Conditions:
SARS-CoV-2
Coronavirus
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The additional effect of personalized health education compared to general education following the internationally accepted principles will be evaluated in the prevention of the serious course of the ...
Detailed Description
PROACTIVE-19 is a pragmatic, randomized controlled clinical trial with adaptive "sample size re-estimation" design. Volunteers will be randomized into two groups: (A) generalized health education; (B)...
Eligibility Criteria
Inclusion
- The inclusion criteria are:
- age over 60 years;
- informed consent to participate.
- The exclusion criteria are:
- confirmed COVID-19 infection (active or recovered);
- hospitalization at screening for eligibility;
- someone was already enrolled in the study from the same community/household (to avoid potential crosstalk between the study arms).
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
449 Patients enrolled
Trial Details
Trial ID
NCT04321928
Start Date
April 1 2020
End Date
September 30 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Translational Medicine, University of Pécs
Pécs, Hungary, 7624